Aisling Capital
New York City, New Yorkaislingcapital.com
Overview
Aisling Capital is a healthcare-focused investment firm that specializes in venture capital and private equity investments in companies developing and commercializing innovative healthcare products, services, and technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Claris Bio | Jul 2026 | Series B | Co-investor |
| Treeline Biosciences | Sep 2025 | Series A | Co-investor |
| Wugen | Aug 2025 | Series C | Co-investor |
| Allotera Therapeutics | Aug 2025 | Series C | Co-investor |
| A2 Biotherapeutics | Jan 2025 | Series C | Co-investor |
Key People
Dennis Purcell
Founder And Senior Advisor
Aftab Kherani
Operating Partner
Scott Braunstein
Operating Partner
Eric Aguiar
Partner
Kevin Yeo
Partner
Sunny Reddy
Principal
Wonpyo Yun
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
